Argentina's Bioceres Q4 revenue nearly flat, gross profit falls
BIOX•Outlook
The company said it will focus on improving performance and cash generation in fiscal 2027.
Bioceres plans further portfolio rationalization and operating efficiencies in the next phase.
The company expects benefits from recent cost actions to support stronger profitability.
Result drivers
- Segment mix — Crop Nutrition revenue grew 36%, offsetting declines in Crop Protection and the impact of the Seeds business reconfiguration.
- Inventory obsolescence — Gross profit was impacted by a $4.0 million non-recurring inventory adjustment related to an updated assessment of inventory obsolescence.
- Cost reductions — Operating expenses declined 19% in Q4, reflecting cost actions implemented during the year.
Q4 revenue nearly flat, gross profit falls
Argentina's ag productivity firm's fiscal Q4 revenue was nearly flat year over year at $55.9 million.
Gross profit declined 6% year over year, impacted by inventory obsolescence charges.
Adjusted EBITDA improved to , supported by lower operating expenses.




